Outcome at D28° |
Treatment group (N) | CF |
Total CF D29-90 | ||||
---|---|---|---|---|---|---|---|
D7-28 | D29-42 | D43-63 | D64-90 | ||||
ACPR
(n = 123) | SP-AS | R | 0 | 0 | 0 | 0 | 0 |
68 | N | 0 | 0 | 2 | 5 | 7 | |
CQ | R | 0 | 1 | 0 | 0 | 1 | |
18 | N | 0 | 1 | 0 | 0 | 1 | |
SP 37 | R | 0 | 1 | 0 | 2 | 3 | |
37 | N | 0 | 0 | 0 | 1 | 1 | |
LPF new infection
(n = 7) | SP-AS | R | 0 | 0 | 0 | 0 | 0 |
4 | N | 0 | 1 | 0 | 0 | 1 | |
CQ | R | 0 | 0 | 0 | 0 | 0 | |
2 | N | 0 | 0 | 0 | 0 | 0 | |
SP | R | 0 | 0 | 0 | 0 | 0 | |
1 | N | 0 | 0 | 0 | 1 | 1 | |
LPF recrudescence
(n = 38) | SP-AS | R | 0 | 0 | 1 | 0 | 1 |
3 | N | 0 | 0 | 0 | 0 | 0 | |
CQ | R | 3 | 0 | 0 | 0 | 3 | |
25 | N | 0 | 0 | 1 | 2 | 3 | |
SP | R | 4 | 0 | 0 | 0 | 4 | |
10 | N | 0 | 0 | 0 | 0 | 0 |